R. Pasquali et al., alpha 2-adrenoceptor regulation of the hypothalamic-pituitary-adrenocortical axis in obesity, CLIN ENDOCR, 52(4), 2000, pp. 413-421
BACKGROUND Abdominal obesity is associated with hyper-responsiveness of the
hypothalamic-pituitary-adrenocortical (HPA) axis to stimulatory neuropepti
des and to stress. Catecholamines are involved in the regulation of the HPA
axis, particularly during stress, via alpha-adrenoceptor modulation.
DESIGN In this study, we investigated the effects of pre-treatment with an
alpha 2-adrenoceptor agonist, clonidine (2 mu g/kg over 10 minutes) and ant
agonist, yohimbine (0.125 mg/kg bolus, followed by 0.001 mg/kg/minutes per
90 minutes infusion) on the HPA axis, measured by ACTH and cortisol respons
e to combined CRH (human, 100 mu g) plus AVP (0.3 IU) administration, and o
n noradrenalin (NA) and adrenalin (A) blood levels, in a group of obese wom
en with abdominal (A-BFD) or peripheral (P-BFD) body fat distribution and i
n nonobese controls.
RESULTS During the control CRH + AVP test the ACTH but not the cortisol res
ponse was higher (P < 0.05) in obese A-BFD women than in controls, with min
or and transient variations of NA levels. Neither the control test nor clon
idine or yohimbine influenced basal or post CRH + AVP A concentrations. Clo
nidine pretreatment similarly and significantly decreased NA levels in all
women and, compared to the control test, marginally influenced the ACTH res
ponse to CRH + AVP. Conversely, during yohimbine infusion NA levels steadil
y and similarly increased to values more or less double baseline values in
all groups. Compared to the control test, however, the ACTH response to the
CRH + AVP test performed during yohimbine infusion significantly decreased
in the control subjects whereas a tendency to a further increase occurred
in the obese groups and, specifically, in the A-BFD group significantly (P
< 0.05) more than in the P-BFD group.
CONCLUSIONS This study shows that alpha 2-adrenoceptor regulation of the HP
A axis is different in obese and nonobese women, particularly in stressed c
onditions. We suggest that the abnormal ACTH response to CRH + AVP challeng
e with increased noradrenergic tone may represent a specific pathophysiolog
ical aspect of the abnormal response to stress or to other specific stimula
tory factors in obese women, particularly those with abdominal body fat dis
tribution.